Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Formoterol Easyhaler pediatric 3-month safety follow-up study
2004-002766-37Phase 3Completed
- Sponsor
- HEXAL AG (Project Management on behalf of the Sponsor: HEXAL Pharmaforschung GmbH
- Start
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of formoterol in asthma and persistent asthma, sponsored by HEXAL AG (Project Management on behalf of the Sponsor: HEXAL Pharmaforschung GmbH. Primary endpoint: Rate of adverse events considering patient compliance. Started Nov 2004; status: completed.
02
Drugs
formoterol
03
Conditions
asthmapersistent asthma
Beyond the preview
Go deeper on 2004-002766-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002766-37.